Marinus Pharmaceuticals Names Dr. Rolando Gutíerrez-Esteinou as VP of Clinical Development and Pharmacovigilance
October 10, 2018 07:30 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
October 09, 2018 16:48 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative...
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 05, 2018 16:00 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative...
Marinus Completes Enrollment in its Magnolia Postpartum Depression Study
September 25, 2018 07:30 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 20, 2018 16:05 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative...
Marinus Appoints Scott Braunstein, MD to its Board of Directors
September 05, 2018 07:30 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
Marinus Pharmaceuticals to Present at the Baird Healthcare Conference
August 30, 2018 16:15 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to...
Marinus Pharmaceuticals to Present at Wedbush/PacGrow Healthcare Conference
August 07, 2018 07:30 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to...
Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results
August 02, 2018 07:30 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative...
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 30, 2018 16:05 ET
|
Marinus Pharmaceuticals, Inc.
RADNOR, Pa., July 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative...